The Odyssey has lost nearly all its shows across India’s IMAX network following the release of Yash-starrer Toxic on August 26. The change comes despite the Christopher Nolan film continuing to attract audiences well into its sixth week and earning close to ₹91 crore from the premium format.
During its first 40 days in Indian cinemas, The Odyssey collected approximately ₹184.23 crore across all formats. Its earnings from IMAX screenings alone stood between ₹90 crore and ₹91 crore, accounting for almost half of its total business in the country.
The film had been playing across 34 IMAX cinemas in India. Even on August 25, the final day of its full-scale IMAX run, it maintained an occupancy rate of around 43% in the format. Discounted ticket prices contributed to the turnout, but several shows continued to fill up despite the film having completed 40 days in theatres.
The film’s distributor reportedly sought one daily show at each IMAX cinema from August 26 because of the continued demand. However, the request was not accepted, with the distributors of Toxic seeking all available IMAX shows for the new release.
One cinema has made an exception. Broadway Cinemas in Coimbatore, Tamil Nadu, will continue screening The Odyssey twice daily, at 11:30 am and 11:00 pm. The same IMAX screen will show Toxic at 7:40 am, 3:10 pm and 7:05 pm.
Over its 40-day theatrical run, The Odyssey earned more than ₹1 crore per day on 33 occasions. The film opened with ₹85.65 crore in its first week, followed by ₹45.67 crore in week two. It collected ₹24.15 crore in its third week, ₹15.65 crore in the fourth and ₹7.74 crore in the fifth. Its first five days of the sixth week added another ₹5.39 crore.
The film may return to more IMAX screens after the initial release period of Toxic. If that happens and audiences continue to turn up, The Odyssey could still have an opportunity to reach the ₹100 crore mark from IMAX screenings alone. However, the interruption to its current run could affect the momentum it had maintained for nearly six weeks.
